Rothschild Investment LLC’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.95K Buy
1,588
+779
+96% +$776 ﹤0.01% 2773
2026
Q1
$568 Buy
+809
New +$755 ﹤0.01% 3080
2025
Q2
– Sell
-360
Closed -$983 – 3129
2025
Q1
$983 Buy
360
+300
+500% +$1.18K ﹤0.01% 2350
2024
Q4
$250 Buy
60
+30
+100% +$113 ﹤0.01% 2741
2024
Q3
$117 Hold
30
– – ﹤0.01% 2832
2024
Q2
$118 Buy
+30
New +$129 ﹤0.01% 2681

Other funds holding MXCT

Rothschild Investment LLC's MXCT Position: Q2 2026 in Review

Rothschild Investment LLC increased its MaxCyte (MXCT) stake by 96% in Q2 2026, buying an estimated $776 and bringing the position to 1,588 shares worth $1.95K. The position accounts for ﹤0.01% of the portfolio, ranked #2773.

Rothschild Investment LLC first reported a position in MXCT in Q2 2024 and has held it in 6 quarters since. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Rothschild Investment LLC held 1,588 shares of MaxCyte worth $1.95K as of Q2 2026.
  • Rothschild Investment LLC bought 779 MaxCyte shares in Q2 2026, an estimated $776.
  • MaxCyte made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2773 holding.
  • Rothschild Investment LLC first reported a position in MaxCyte in Q2 2024 and has held it in 6 quarters since.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.